Evidence map›Paper›PMID 29269655›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Chronic Brachial Plexus Neuritis That Developed into Typical Neuralgic Amyotrophy and Positively Responded to Immunotherapy.

Ryo Morishima, Utako Nagaoka, Masahiro Nagao, Eiji Isozaki

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuralgic Amyotrophy: Its Importance in Orthopedics Practice.Spine surgery and related research · 2021
    Review
  4. A case of painless neuralgic amyotrophy responsive to immunotherapy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  5. Review
  6. Article
  7. Brachial Plexopathies: Update on Treatment.Current treatment options in neurology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ryo MorishimaDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Utako NagaokaDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Masahiro NagaoDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Eiji IsozakiDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Japan.
Tokyo Metropolitan Neurological Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on the hypothesis that autoimmunity plays a role in the pathogenesis of neuralgic amyotrophy (NA), immunotherapy is sometimes administered. Early intervention is recommended for a good prognosis. We herein report the case of a 55-year-old man who presented with neuralgia, weakness, and muscle atrophy in his right shoulder girdle and upper arm, which progressed for ten months following a marine sports accident. The patient was diagnosed with NA. His neurological deficits gradually improved after several courses of immunotherapy, suggesting that in addition to being effective for treating early-stage disease, immunotherapy may be effective for treating chronic cases.

Indexed as

Brachial PlexusBrachial Plexus NeuritisChronic DiseaseCritical CareHumansImmunotherapyMaleMiddle AgedMuscular AtrophyNeuralgiaTreatment Outcomechronic brachial plexus neuritisintravenous immunoglobulinneuralgic amyotrophy

Identifiers

PMID29269655
PMCPMC5919865
OpenAlexW2780718174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.